| 000 | 01819 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517194000.0 | ||
| 264 | 0 | _c20190627 | |
| 008 | 201906s 0 0 eng d | ||
| 022 | _a1572-0241 | ||
| 024 | 7 |
_a10.1038/ajg.2017.482 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJeuring, Steven F G | |
| 245 | 0 | 0 |
_aCorticosteroid Sparing in Inflammatory Bowel Disease is More Often Achieved in the Immunomodulator and Biological Era-Results from the Dutch Population-Based IBDSL Cohort. _h[electronic resource] |
| 260 |
_bThe American journal of gastroenterology _c03 2018 |
||
| 300 |
_a384-395 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdrenal Cortex Hormones _xtherapeutic use |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBiological Products _xtherapeutic use |
| 650 | 0 | 4 |
_aColitis, Ulcerative _xdrug therapy |
| 650 | 0 | 4 |
_aCrohn Disease _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunologic Factors _xtherapeutic use |
| 650 | 0 | 4 |
_aInflammatory Bowel Diseases _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNetherlands |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aBiemans, Vince B C | |
| 700 | 1 | _avan den Heuvel, Tim R A | |
| 700 | 1 | _aZeegers, Maurice P | |
| 700 | 1 | _aHameeteman, Wim H | |
| 700 | 1 | _aRomberg-Camps, Mariëlle J L | |
| 700 | 1 | _aOostenbrug, Liekele E | |
| 700 | 1 | _aMasclee, Ad A M | |
| 700 | 1 | _aJonkers, Daisy M A E | |
| 700 | 1 | _aPierik, Marieke J | |
| 773 | 0 |
_tThe American journal of gastroenterology _gvol. 113 _gno. 3 _gp. 384-395 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/ajg.2017.482 _zAvailable from publisher's website |
| 999 |
_c27964349 _d27964349 |
||